Sign In
29 Oct 2010 11:34
ļ»æ
Ā
Instem Life Science SystemsĀ plcĀ ('the Company')
29 October 2010
Ā
VOTING RIGHTS AND CAPITAL
Ā
In conformity with the Disclosure and Transparency Rules we would like to notify the market of the following:Ā
Ā
The Company'sĀ issuedĀ shareĀ capital consists ofĀ 11,714,286 ordinary shares with a nominal value ofĀ 10p each ('Ordinary Shares').Ā The CompanyĀ does not holdĀ anyĀ OrdinaryĀ Shares in Treasury.
Ā
Therefore, the total number of votingĀ rights inĀ the CompanyĀ isĀ 11,714,286
Ā
The figure ofĀ 11,714,286 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in,Ā the CompanyĀ under the FSA's Disclosure andĀ TransparencyĀ Rules.
Ā
For further information, please contact:
Ā
Instem Life Science Systems plc | +44 (0) 1785 825600 |
Phil Reason, CEO | |
Jim McLauchlan, CFO | |
Brewin Dolphin - Financial Advisor, Broker & NOMAD | +44 (0) 0845 213 4730 |
Mark Brady | |
Sean Wyndham-Quin | |
Rickitt Mitchell - Joint Financial Advisor to the Company | +44 (0) 161 834 0600 |
Matthew Bryden-Smith | |
Neil Mitchell | |
Threadneedle Communications | +44 (0) 20 7653 9850 |
Caroline Evans-Jones | |
Fiona Conroy | |
Josh Royston |
Ā
Ā
Follow the stocks
